Schedule 13D ownership disclosure
PRANA BIOTECHNOLOGY LTD SHS (A
Security class unavailable · CUSIP: Q7739U108
Event date: 2019-12-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 269,905,533
- Percent of class
- 30.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-19-075581
- Form type
- SC 13D
- Filer
- ALTERITY THERAPEUTICS LTD
- CIK
- CIK 1131343
- Filed
- Dec 23, 2019
- Reporting period
- Dec 19, 2019
- Description
- Schedule 13D beneficial ownership